Form D Explorer
ASCENDIA PHARMACEUTICALS, INC. · CIK 1855888

Report a data issueCitable research briefCompare issuerPrivate research collection

ASCENDIA PHARMACEUTICALS, INC.

CIK 1855888 · Corporation · Inc. DELAWARE · NORTH BRUNSWICK, New Jersey · Other Health Care

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

From Jun 4, 2025 to Nov 6, 2026, the explorer stores 2 original notices and 1 amendments. The Nov 6, 2026 filing reports $4,084,536 offered and $4,084,536 sold.

Filings
3
Original notices
2
Amendments
1
Activity
Jun 4, 2025
through Nov 6, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJul 24, 2026 · DNov 6, 2026 · D/ALater minus earlier
Reported offering amount$4,084,536$4,084,536$0
Reported amount sold$4,084,536$4,084,536$0
Reported investor count330
Reported minimum investment$500,000$500,000$0

Earlier SEC source: 0001855888-26-000005 · Later SEC source: 0001855888-26-000008

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Nov 6, 2026

Reported offering amount
$4,084,536
Reported exemptions
Rule 506(b)
Reported amount sold
$4,084,536

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (3)